References
- Cagnacci A, Carbone MM, Palma F, et al. Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study. Menopause 2016;23:1139–45
- Simon JA, Kokot-Kierepa M, Goldstein J, et al. Vaginal health in the United States: results from the vaginal health: insights, views & attitudes survey. Menopause 2013;20:1043–8
- Palacios S, Cancelo MJ, Castelo Branco C, et al. Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions. Climacteric 2017;20:55–61
- Erekson EA, Li FY, Martin DK, et al. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Menopause 2016;23:368–75
- Aydin Y, Hassa H, Oge T, et al. Frequency and determinants of urogenital symptoms in postmenopausal Islamic women. Menopause 2014;21:182–7
- Trutnovsky G, Rojas RG, Mann KP, et al. Urinary incontinence: the role of menopause. Menopause 2014;21:399–402
- Manonai J, Chittacharoen A, Sarit-Apirak S, et al. Lower urinary tract symptoms in Thai women attending the menopause clinic: prevalence and associated factors. J Med Assoc Thailand 2004;87:1265–9
- Portman DJ, Gass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the international society for the study of women's sexual health and the North American menopause society. Climacteric 2014;17:557–63
- Palacios S, Castelo-Branco C, Currie H, et al. Update on management of genitourinary syndrome of menopause: a practical guide. Maturitas 2015;82:308–13
- Calleja-Agius J, Brincat MP. Urogenital atrophy. Climacteric 2009;12:279–85
- DiBonaventura M, Luo X, Moffatt M, et al. The association between vulvovaginal atrophy symptoms and quality of life among postmenopausal women in the United States and Western Europe. J Women's Health 2015;24:713–22
- Nappi RE, Palacios S, Panay N, et al. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric 2016;19:188–97
- Palma F, Della Vecchia E, Cagnacci A, et al. Medical and patient attitude towards vaginal atrophy: the AGATA study. Climacteric 2016;19:553–7
- Chua Y, Limpaphayom KK, Cheng B, et al. Genitourinary syndrome of menopause in five Asian countries: results from the Pan-Asian REVIVE survey. Climacteric 2017;20:367–73
- Palma F, Xholli A, Cagnacci A, et al. Management of vaginal atrophy: a real mess. Results from the AGATA study. Gynecol Endocrinol 2017;33:702–7
- Tao M, Teng Y, Shao H, et al. Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: a systematic review and meta-synthesis. PloS One 2011;6:e24661
- Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105–14
- Gandhi J, Chen A, Dagur G, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol 2016;215:704–11
- Ruan X, Cui Y, Du J, et al. Prevalence of climacteric symptoms comparing perimenopausal and postmenopausal Chinese women. J Psychosom Obstet Gynaecol 2011;38:161–9
- Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 2014;17:3–9
- North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of the North American menopause society. Menopause 2007;14:355–69
- Jiang Y, Yan L, Du FD, et al. [Prevalence and associated factors of female urinary incontinence in Hebei province]. Zhonghua Fu Chan Ke Za Zhi 2016;51:914–20
- Huang AJ, Moore EE, Boyko EJ, et al. Vaginal symptoms in postmenopausal women: self-reported severity, natural history, and risk factors. Menopause 2010;17:121–6
- Pace G, Silvestri V, Guala L, et al. Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health. Menopause 2009;16:1188–92
- Sever N, Oskay U. An investigation of lower urinary tract symptoms in women aged 40 and over. Low Urin Tract Symptoms 2017;9:21–6
- Yokota M, Makita K, Hirasawa A, et al. Symptoms and effects of physical factors in Japanese middle-aged women. Menopause 2016;23:974–83